Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MRM
stocks logo

MRM

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for Medirom Healthcare Technologies Inc (MRM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Medirom Healthcare Technologies Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
2.05
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
6.58
Undervalued EV/EBITDA
-2.48

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.03
Current PS
0.00
Overvalued PS
0.11
Undervalued PS
-0.05
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

MRM News & Events

Events Timeline

(ET)
2025-10-29
10:25:23
Medirom Healthcare to Introduce New Treasury Strategy Utilizing Cryptocurrency
select
2025-10-28 (ET)
2025-10-28
08:36:02
Medirom Healthcare reports that more than 10,000 individuals have obtained World IDs at various locations.
select
2025-10-09 (ET)
2025-10-09
08:08:59
Medirom Mother Labs Secures Funding from Internal Investors
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
07:13 AMNewsfilter
MEDIROM Partners with TD SYNNEX to Accelerate Nationwide Expansion of Health-Tech Products
  • Distributor Agreement Signed: MEDIROM's subsidiary MOTHER Labs has entered into a distribution agreement with TD SYNNEX, leveraging the latter's nationwide sales network in Japan to accelerate the promotion of the recharge-free smart tracker MOTHER Bracelet® and the remote health monitoring system REMONY®.
  • Market Expansion Potential: With a global network spanning over 100 countries and partnerships with more than 1,500 manufacturers, TD SYNNEX is expected to enhance the adoption of MOTHER Labs' products in the Japanese market through its extensive product portfolio.
  • Technological Innovation Advantage: The MOTHER Bracelet® is the world's first 24/7 recharge-free smart tracker, capable of recording five health metrics in real-time, thus eliminating the risk of data loss during charging and significantly enhancing user experience.
  • Wide Industry Applications: The REMONY system, which integrates the MOTHER Bracelet® with a dedicated gateway, enables real-time data synchronization and centralized management, making it suitable for various industries such as elder care and health monitoring for night shift workers, showcasing significant market application potential.
[object Object]
Preview
7.5
06:22 AMGlobenewswire
MEDIROM Partners with TD SYNNEX to Expand Health-Tech Solutions Nationwide
  • Partnership Agreement: MEDIROM MOTHER Labs has signed a distribution agreement with TD SYNNEX to leverage its nationwide sales network in Japan, aiming to accelerate the rollout of the recharge-free smart tracker MOTHER Bracelet® and the remote health monitoring system REMONY®, thereby enhancing market penetration.
  • Product Innovation: The MOTHER Bracelet® is the world's first 24/7 recharge-free smart tracker that can continuously record five health metrics—heart rate, calories burned, body surface temperature, step count, and sleep—eliminating data loss during charging, which significantly enhances user experience.
  • Market Expansion Potential: TD SYNNEX's proven track record in promoting overseas smart trackers in the Japanese market will provide robust support for MOTHER Labs, with expectations to significantly increase the nationwide implementation of health management and safety solutions to meet growing market demand.
  • Strategic Collaboration Outlook: This partnership will not only promote the adoption of health tech products but also lay the groundwork for MEDIROM's long-term growth in the health management sector, further solidifying its competitive position in the industry.
[object Object]
Preview
7.5
06:15 AMYahoo Finance
MEDIROM Mother Labs Collaborates with TD SYNNEX to Boost Nationwide Adoption of "MOTHER Bracelet" and "REMONY"

  • Partnership Announcement: MEDIROM Healthcare Technologies' subsidiary, MOTHER Labs, has signed a distributor agreement with TD SYNNEX K.K. to enhance the distribution of its health-tech products, including the MOTHER Bracelet® and REMONY® system, across Japan.

  • Innovative Health Solutions: The MOTHER Bracelet® is a unique, recharge-free smart tracker that continuously monitors vital health metrics, while the REMONY® system integrates this tracker with a gateway for real-time health data management, addressing common issues with conventional wearables.

  • Market Expansion Strategy: TD SYNNEX's extensive sales network and experience in the Japanese market will support MOTHER Labs in promoting health management solutions, particularly in sectors like elder care and logistics.

  • Company Overview: MOTHER Labs focuses on health-tech innovations, including the Specific Health Guidance Program and customizable health management solutions, while also operating a running station to support health management for runners.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Medirom Healthcare Technologies Inc (MRM) stock price today?

The current price of MRM is 2.135 USD — it has increased 4.66 % in the last trading day.

arrow icon

What is Medirom Healthcare Technologies Inc (MRM)'s business?

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.

arrow icon

What is the price predicton of MRM Stock?

Wall Street analysts forecast MRM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRM is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Medirom Healthcare Technologies Inc (MRM)'s revenue for the last quarter?

Medirom Healthcare Technologies Inc revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Medirom Healthcare Technologies Inc (MRM)'s earnings per share (EPS) for the last quarter?

Medirom Healthcare Technologies Inc. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Medirom Healthcare Technologies Inc (MRM)'s fundamentals?

The market is revising No Change the revenue expectations for MRM for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 30.18%.
arrow icon

How many employees does Medirom Healthcare Technologies Inc (MRM). have?

Medirom Healthcare Technologies Inc (MRM) has 334 emplpoyees as of December 05 2025.

arrow icon

What is Medirom Healthcare Technologies Inc (MRM) market cap?

Today MRM has the market capitalization of 16.87M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free